scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1008410004 |
P356 | DOI | 10.1245/S10434-014-3798-Z |
P698 | PubMed publication ID | 24854493 |
P50 | author | Guillermo Flores-Ayala | Q114522558 |
Alberto Gomez-Portilla | Q114522559 | ||
Mecker Moller | Q114522560 | ||
Guillaume Passot | Q114522561 | ||
Marc Pocard | Q114522562 | ||
George Salti | Q114522564 | ||
Juan Torres-Melero | Q114522565 | ||
Marcello Deraco | Q43800082 | ||
Dario Baratti | Q43800097 | ||
Armando Sardi | Q57019761 | ||
Olivier Glehen | Q57655409 | ||
Shigeki Kusamura | Q59555769 | ||
Kiran K Turaga | Q84946648 | ||
Richard Berri | Q85408607 | ||
Jesus Esquivel | Q88222940 | ||
Evgenia Halkia | Q88925925 | ||
Santiago González-Moreno | Q89017697 | ||
Terence C Chua | Q90254454 | ||
Andrew M Lowy | Q90616308 | ||
Maheswari Senthil | Q96341637 | ||
Joerg O Pelz | Q114522554 | ||
Joel M Baumgartner | Q114522556 | ||
Pedro Bretcha-Boix | Q114522557 | ||
P2093 | author name string | Maurie Markman | |
Richard Trout | |||
John Spilioitis | |||
Martin Goodman | |||
P2860 | cites work | Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 |
Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin | Q33777576 | ||
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial | Q34581085 | ||
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen | Q34642136 | ||
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. | Q35721069 | ||
Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. | Q36571925 | ||
Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy | Q37662262 | ||
Summary of current therapeutic options for peritoneal metastases from colorectal cancer | Q38017942 | ||
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States | Q38116391 | ||
Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 | ||
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity. | Q46755325 | ||
Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. | Q47787166 | ||
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study | Q53264117 | ||
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. | Q53286355 | ||
P433 | issue | 13 | |
P921 | main subject | colorectal cancer | Q188874 |
colorectal carcinoma | Q25493920 | ||
P304 | page(s) | 4195-4201 | |
P577 | publication date | 2014-05-23 | |
P1433 | published in | Annals of Surgical Oncology | Q2853069 |
P1476 | title | The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis | |
P478 | volume | 21 |
Q60922822 | A Simplified Peritoneal Sarcomatosis Score for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
Q26772268 | Abdominal metastases from colorectal cancer: intraperitoneal therapy |
Q37280394 | Bowel strangulation caused by massive intraperitoneal adhesion due to effective chemotherapy for multiple peritoneal metastases originating from descending colon cancer |
Q47849422 | Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review. |
Q64092130 | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
Q53102271 | Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort. |
Q36762307 | Computerized System for Staging Peritoneal Surface Malignancies |
Q49774282 | Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and meta-analysis |
Q64116538 | Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study |
Q39964992 | Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors. |
Q36160064 | Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details |
Q26768376 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection |
Q41547533 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence |
Q52974833 | Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC. |
Q28077394 | Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis |
Q92200782 | Impact of anesthesia management during cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for the treatment of colorectal peritoneal carcinomatosis on intra- and postoperative outcomes: A systematic review protocol |
Q26849259 | Looking up: Recent advances in understanding and treating peritoneal carcinomatosis |
Q37571642 | Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature |
Q26769938 | Multimodality treatment strategies have changed prognosis of peritoneal metastases |
Q60912302 | Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study |
Q91671852 | Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer |
Q39442876 | Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer |
Q40242470 | Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis |
Q94410844 | Preoperative Management of Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy |
Q90392289 | Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC |
Q47789478 | Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. |
Q38765792 | Registries on peritoneal surface malignancies throughout the world, their use and their options. |
Q64064235 | Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial |
Q37354819 | Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery |
Q38780368 | Surveillance after curative treatment for colorectal cancer |
Q51000263 | Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer. |
Q40507435 | The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score. |
Q28067123 | Therapeutic options for peritoneal metastasis arising from colorectal cancer |
Q39406537 | Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer. |
Q26744031 | Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives |
Q38816501 | What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures |
Search more.